Greenlight Capital, Inc. 13F holdings and portfolio analysis
Sign in to clone a new branch from the selected plan, then continue optimizing in the new branch.
Baseline
Analysis messagesPre-generated Q&A about this fund. Use as reference context for your own analysis.
The latest change list shows GRBK unchanged to 21.52%; FLR unchanged to 7.99%; CNR unchanged to 6.74%. Combined with top 5 47.41%, top 10 67.26%, top 20 90.02%, that tells the user whether the baseline is becoming more concentrated or simply refreshing existing exposure. For a static page, this is the best first check before deciding whether the raw disclosed book is still acceptable.
The strongest recent period was 2025-09-30 (2.95% strategy return, 1.46% benchmark, 1.49% excess, 14.64% turnover), while the weakest was 2025-03-31 (-0.12% strategy return, 9.22% benchmark, -9.33% excess, 11.05% turnover). Those periods should be read alongside baseline metrics of return 6.14%, alpha -2.49%, beta 0.67, Sharpe 0.45, Sortino 0.55, and max drawdown -40.46% to judge whether returns came from persistent exposure or a narrow timing window.
Concentration is the first item to inspect: top 5 47.41%, top 10 67.26%, top 20 90.02%. The largest names are GRBK (Green Brick Partners, Inc.) 21.52%, FLR (Fluor Corporation) 7.99%, CNR (Core Natural Resources, Inc.) 6.74%, BHF (Brighthouse Financial, Inc.) 6.56%, and GPK (Graphic Packaging Holding Company) 4.60%, and the largest sector exposures are Consumer Discretionary 34.41%, Energy 14.66%, and Health Care 14.18%. If those exposures reverse, baseline performance can diverge sharply from a broad index.